(Q47276359)

13 January 2018

title

Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis (English)

1 reference

13 January 2018

0 references

5

B Peplonska

1 reference

13 January 2018

author name string

B Zakrzewska-Pniewska

1

1 reference

13 January 2018

M Styczynska

2

1 reference

13 January 2018

A Podlecka

3

1 reference

13 January 2018

R Samocka

4

1 reference

13 January 2018

M Barcikowska

6

1 reference

13 January 2018

H Kwiecinski

7

1 reference

13 January 2018

publication date

1 June 2004

1 reference

13 January 2018

Multiple Sclerosis Journal

published in

1 reference

13 January 2018

volume

10

1 reference

13 January 2018

issue

3

1 reference

13 January 2018

page(s)

266-271

1 reference

13 January 2018

Identifying disease modifying genes in multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

APOE genotype is a major predictor of long-term progression of disability in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Living with a killer: the effects of hypochlorous acid on mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1015OA

10.1191/1352458504MS1015OA

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018